Home - Products - Others - Other Targets - Kaempferol-7-O-β-D-glucopyranoside

Kaempferol-7-O-β-D-glucopyranoside

CAS No. 16290-07-6

Kaempferol-7-O-β-D-glucopyranoside ( Kaempferol-7-O-D-glucopyranoside )

Catalog No. M28330 CAS No. 16290-07-6

Kaempferol-7-O-D-glucopyranoside, a novel supercoolant could be used to sub-zero non-freezing rat heart preservation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 331 Get Quote
10MG 495 Get Quote
25MG 798 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Kaempferol-7-O-β-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Kaempferol-7-O-D-glucopyranoside, a novel supercoolant could be used to sub-zero non-freezing rat heart preservation.
  • Description
    Kaempferol-7-O-D-glucopyranoside, a novel supercoolant could be used to sub-zero non-freezing rat heart preservation.
  • Synonyms
    Kaempferol-7-O-D-glucopyranoside
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16290-07-6
  • Formula Weight
    448.4
  • Molecular Formula
    C21H20O11
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@H]1Oc(cc1O)cc(OC(c(cc2)ccc2O)=C2O)c1C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sellami A, Montes M, Lagarde N. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods. Int J Mol Sci. 2021 Mar 11;22(6):2846.
molnova catalog
related products
  • Pidotimod

    Pidotimod is an immunostimulant.

  • LIT-001

    LIT-001 improves social interaction in a mouse model of autism.It is the first nonpeptide oxytocin receptor agonist with EC50 of 55 nM and Ki of 226 nM.

  • Nyasol

    Nyasol may have potential to be developed as medicines for the treatment of allergies by inhibiting the activation of mast cells.